Home Featured Page 225

Featured

Latest

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout...

PTSF76 – Spiritual Emergence and Healing

Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds

atai Life Sciences and Introspect Digital Therapeutics to test novel digital...

MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible...

Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum...

Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst...

Wesana Health Announces Closing of PsyTech Acquisition

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering...

1...224225226...304 Page 225 of 304

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

The Psychedelic News Feed: December 1 – 7, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout...

PTSF76 – Spiritual Emergence and Healing

Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds

atai Life Sciences and Introspect Digital Therapeutics to test novel digital...

MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible...

Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum...

Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst...

Wesana Health Announces Closing of PsyTech Acquisition

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering...

EDITOR PICKS

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

The Psychedelic News Feed: December 1 – 7, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY